Translate this page into:
Corrigendum: Direct-acting antiviral agents in Hepatitis C Virus infected renal allograft recipients: Treatment and outcome experience from single center
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
In the article titled “Direct-acting antiviral agents in Hepatitis C Virus infected renal allograft recipients: Treatment and outcome experience from single center”, published on pages 220-225, Issue 3, Volume 28 of Indian Journal of Nephrology,[1] the figure label “Tacrolimus trough level (ng/ml)” was misspelled as “Tacrolimus trough level (ng/dl)” in Tables 2 and 3 on page 223, and in Figure 4 on page 224.
The correct text should be read as “Tacrolimus trough level (ng/ml)”
Reference
- Direct-acting antiviral agents in Hepatitis C Virus infected renal allograft recipients: Treatment and outcome experience from single center. Indian J Nephrol. 2018;28:220-5.
- [Google Scholar]
